Wealth Alliance Advisory Group, LLC Vivos Therapeutics, Inc. Transaction History

Wealth Alliance Advisory Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.32 - $1.88 $2,800 - $16,451	-8,751 Reduced 33.34%	17,498 $5,000
Q4 2022 Jan 17, 2023	SELL	$0.35 - $20.75 $3,062 - $181,583	-8,751 Reduced 25.0%	26,249 $0
Q3 2022 Oct 12, 2022	BUY	$0.83 - $21.25 $29,050 - $743,750	35,000 New	35,000 $23,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.